Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,500 | 47,086 | 35,004 | 50,588 | 37,981 |
| Marketable Securities | 54,927 | 51,097 | 52,321 | 49,466 | 50,598 |
| Receivables | 141,307 | 61,090 | 66,292 | 54,120 | 44,944 |
| Inventories | 24,763 | 32,880 | 39,403 | 38,308 | 39,788 |
| TOTAL | $263,573 | $210,209 | $213,550 | $202,549 | $181,156 |
| Non-Current Assets | |||||
| PPE Net | 479 | 515 | 550 | 586 | 624 |
| Intangibles | 54,711 | 62,006 | 71,238 | 80,471 | 92,359 |
| Other Non-Current Assets | 1,012 | 1,050 | 1,088 | 1,126 | 1,860 |
| TOTAL | $56,202 | $63,571 | $72,876 | $82,183 | $94,843 |
| Total Assets | $319,775 | $273,780 | $286,426 | $284,732 | $275,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,664 | 10,854 | 8,896 | 14,736 | 13,153 |
| Accrued Expenses | 146,799 | 116,942 | 115,167 | 95,151 | 73,446 |
| Other current liabilities | 5,320 | 4,733 | 4,769 | 4,801 | 3,505 |
| TOTAL | $166,783 | $132,529 | $128,832 | $114,688 | $90,104 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,166 | 39,046 | 38,929 | 38,813 | 38,840 |
| Other Non-Current Liabilities | 8,023 | 8,907 | 10,135 | 10,150 | 16,537 |
| TOTAL | $47,189 | $47,953 | $49,064 | $48,963 | $55,377 |
| Total Liabilities | $213,972 | $180,482 | $177,896 | $163,651 | $145,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,252 | 96,240 | 95,781 | 95,773 | 95,478 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -691,572 | -703,017 | -686,665 | -673,124 | -662,648 |
| TOTAL | $105,803 | $93,298 | $108,530 | $121,081 | $130,518 |
| Total Liabilities And Equity | $319,775 | $273,780 | $286,426 | $284,732 | $275,999 |